|
|
Volumn 47, Issue 2, 1992, Pages 159-166
|
|
The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group study
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ADULT;
AGED;
CANCER CELL;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CELL TYPE;
CONFERENCE PAPER;
HUMAN;
LENGTH OF STAY;
MAJOR CLINICAL STUDY;
OVARY CANCER;
PELVIS TUMOR;
PRIORITY JOURNAL;
PROGNOSIS;
TUMOR VOLUME;
ADULT;
AGED;
AGED, 80 AND OVER;
CARCINOMA;
FEMALE;
HUMAN;
MIDDLE AGE;
NEOPLASM STAGING;
OVARIAN NEOPLASMS;
PROPORTIONAL HAZARDS MODELS;
RECURRENCE;
REGRESSION ANALYSIS;
SUPPORT, U.S. GOV'T, P.H.S.;
SURVIVAL ANALYSIS;
|
|
EID: 0026620239
PISSN: 00908258
EISSN: 10956859
Source Type: Journal
DOI: 10.1016/0090-8258(92)90100-W Document Type: Article |
|
Times cited : (509)
|
|
References (13)
|
